These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 38497749)

  • 21. Integrating in Silico and in Vitro Approaches To Predict Drug Accessibility to the Central Nervous System.
    Zhang YY; Liu H; Summerfield SG; Luscombe CN; Sahi J
    Mol Pharm; 2016 May; 13(5):1540-50. PubMed ID: 27015243
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A review on machine learning approaches and trends in drug discovery.
    Carracedo-Reboredo P; Liñares-Blanco J; Rodríguez-Fernández N; Cedrón F; Novoa FJ; Carballal A; Maojo V; Pazos A; Fernandez-Lozano C
    Comput Struct Biotechnol J; 2021; 19():4538-4558. PubMed ID: 34471498
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A curated diverse molecular database of blood-brain barrier permeability with chemical descriptors.
    Meng F; Xi Y; Huang J; Ayers PW
    Sci Data; 2021 Oct; 8(1):289. PubMed ID: 34716354
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Blood Brain Barrier Permeability Prediction Using Machine Learning Techniques: An Update.
    Saxena D; Sharma A; Siddiqui MH; Kumar R
    Curr Pharm Biotechnol; 2019; 20(14):1163-1171. PubMed ID: 31433750
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of Human in vitro Brain-blood Barrier Model from Induced Pluripotent Stem Cell-derived Endothelial Cells to Predict the in vivo Permeability of Drugs.
    Li Y; Sun X; Liu H; Huang L; Meng G; Ding Y; Su W; Lu J; Gong S; Terstappen GC; Zhang R; Zhang W
    Neurosci Bull; 2019 Dec; 35(6):996-1010. PubMed ID: 31079318
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A machine learning-based quantitative model (LogBB_Pred) to predict the blood-brain barrier permeability (logBB value) of drug compounds.
    Shaker B; Lee J; Lee Y; Yu MS; Lee HM; Lee E; Kang HC; Oh KS; Kim HW; Na D
    Bioinformatics; 2023 Oct; 39(10):. PubMed ID: 37713469
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mimicking brain tissue binding in an in vitro model of the blood-brain barrier illustrates differences between in vitro and in vivo methods for assessing the rate of brain penetration.
    Heymans M; Sevin E; Gosselet F; Lundquist S; Culot M
    Eur J Pharm Biopharm; 2018 Jun; 127():453-461. PubMed ID: 29602020
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A classification model for blood brain barrier penetration.
    Singh M; Divakaran R; Konda LSK; Kristam R
    J Mol Graph Model; 2020 May; 96():107516. PubMed ID: 31940508
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Microfluidic blood-brain barrier model provides in vivo-like barrier properties for drug permeability screening.
    Wang YI; Abaci HE; Shuler ML
    Biotechnol Bioeng; 2017 Jan; 114(1):184-194. PubMed ID: 27399645
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Does VEGF secreted by leukemic cells increase the permeability of blood-brain barrier by disrupting tight-junction proteins in central nervous system leukemia?
    Feng S; Huang Y; Chen Z
    Med Hypotheses; 2011 May; 76(5):618-21. PubMed ID: 21398042
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development and validation of PAMPA-BBB QSAR model to predict brain penetration potential of novel drug candidates.
    Kato R; Zeng W; Siramshetty VB; Williams J; Kabir M; Hagen N; Padilha EC; Wang AQ; Mathé EA; Xu X; Shah P
    Front Pharmacol; 2023; 14():1291246. PubMed ID: 38108064
    [TBL] [Abstract][Full Text] [Related]  

  • 32. QSAR modeling of the blood-brain barrier permeability for diverse organic compounds.
    Zhang L; Zhu H; Oprea TI; Golbraikh A; Tropsha A
    Pharm Res; 2008 Aug; 25(8):1902-14. PubMed ID: 18553217
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rapid Quantification of Microvessels of Three-Dimensional Blood-Brain Barrier Model Using Optical Coherence Tomography and Deep Learning Algorithm.
    Zhang H; Kang DH; Piantino M; Tominaga D; Fujimura T; Nakatani N; Taylor JN; Furihata T; Matsusaki M; Fujita S
    Biosensors (Basel); 2023 Aug; 13(8):. PubMed ID: 37622905
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An Improved In Vitro Porcine Blood-Brain Barrier Model for Permeability Screening and Functional Studies.
    Patabendige A
    Methods Mol Biol; 2022; 2492():131-142. PubMed ID: 35733042
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Human Immortalized Cell-Based Blood-Brain Barrier Triculture Model: Development and Characterization as a Promising Tool for Drug-Brain Permeability Studies.
    Ito R; Umehara K; Suzuki S; Kitamura K; Nunoya KI; Yamaura Y; Imawaka H; Izumi S; Wakayama N; Komori T; Anzai N; Akita H; Furihata T
    Mol Pharm; 2019 Nov; 16(11):4461-4471. PubMed ID: 31573814
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of selection of molecular descriptors on the prediction of blood-brain barrier penetrating and nonpenetrating agents by statistical learning methods.
    Li H; Yap CW; Ung CY; Xue Y; Cao ZW; Chen YZ
    J Chem Inf Model; 2005; 45(5):1376-84. PubMed ID: 16180914
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Can we predict blood brain barrier permeability of ligands using computational approaches?
    Kumar R; Sharma A; Tiwari RK
    Interdiscip Sci; 2013 Jun; 5(2):95-101. PubMed ID: 23740390
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Utilizing machine learning techniques to predict the blood-brain barrier permeability of compounds detected using LCQTOF-MS in Malaysian Kelulut honey.
    Edros R; Feng TW; Dong RH
    SAR QSAR Environ Res; 2023; 34(6):475-500. PubMed ID: 37409842
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prediction of blood-brain barrier permeation of α-adrenergic and imidazoline receptor ligands using PAMPA technique and quantitative-structure permeability relationship analysis.
    Vucicevic J; Nikolic K; Dobričić V; Agbaba D
    Eur J Pharm Sci; 2015 Feb; 68():94-105. PubMed ID: 25542610
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ensemble modeling with machine learning and deep learning to provide interpretable generalized rules for classifying CNS drugs with high prediction power.
    Yu TH; Su BH; Battalora LC; Liu S; Tseng YJ
    Brief Bioinform; 2022 Jan; 23(1):. PubMed ID: 34530437
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.